NASDAQ:CLIN - Nasdaq - US1844931048 - Common Stock - Currency: USD
MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash | 0.00 | 600.00K | 0.00 | |||
Marketable Securities | 86.00M | 235.60M | N/A | |||
Receivables | 0.00 | 0.00 | 0.00 | |||
Other Current Assets | 300.00K | 300.00K | N/A | |||
Total Current Assets | 86.30M | 236.50M | 0.00 | |||
Non-Current Assets | ||||||
Other Non-Current Assets | N/A | 0.00 | 700.00K | |||
Total Non-Current Assets | 0.00 | 0.00 | N/A | |||
TOTAL ASSETS | 86.30M | 236.50M | 700.00K | |||
LIABILITIES | ||||||
Current Liabilities | ||||||
Short Term Debt | 0.00 | 0.00 | 0.00 | |||
Accrued Expenses | 2.20M | 2.60M | 600.00K | |||
Accounts Payable | 200.00K | 0.00 | N/A | |||
Other Current Liabilities | 2.50M | 5.20M | 100.00K | |||
Total Current Liabilities | 4.90M | 7.90M | 700.00K | |||
Non-Current Liabilities | ||||||
Long Term Debt | 0.00 | 0.00 | 0.00 | |||
Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | |||
TOTAL LIABILITIES | 4.90M | 7.90M | 700.00K | |||
SHAREHOLDERS' EQUITY | ||||||
Retained Earnings | -4.70M | -6.90M | 0.00 | |||
Additional Paid In Capital | 0.00 | 0.00 | 0.00 | |||
Common Shares | 86.00M | 235.60M | 0.00 | |||
Shares Outstanding | 16.70M | 31.60M | 27.70M | |||
Tangible Book Value per Share | 4.87 | 7.24 | 0.00 | |||
Total Shareholders' Equity | 81.40M | 228.70M | 0.00 | |||
TOTAL LIABILITIES AND EQUITY | 86.30M | 236.50M | 700.00K | |||
Statistics | ||||||
Current Ratio | 17.61 | 29.94 | N/A | |||
Return On Assets (ROA) | 4.82% | 0.03% | N/A | |||
Return On Equity (ROE) | 5.11% | 0.03% | N/A |
All data in USD , ROIC based on taxRate of 0.21